RecruitingPHASE1, PHASE2NCT06648096

Afatinib in Patients with Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

Studying Fanconi anemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Principal Investigator
Jordi Surrallés, M.D.; Ph.D.
Sant Pau's Hospital Research Institute
Intervention
Afatinib(drug)
Enrollment
25 enrolled
Eligibility
18 years · All sexes
Timeline
2024 – 2028

Study locations (2)

Collaborators

MFAR Clinical Research S.L.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06648096 on ClinicalTrials.gov

Other trials for Fanconi anemia

Additional recruiting or active studies for the same condition.

See all trials for Fanconi anemia →

← Back to all trials